Ethyl 5-oxo-2,5-dihydro-1,2,4-oxadiazole-3-carboxylate, 98%, 10g

1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyrrolo[2,3-c]pyridine, 95.0%, 500mg

(3-Chloro-5-(trifluoromethyl)pyridin-2-yloxy)acetic acid, 95.0%, 1g

4-Acetamidocyclohexanol (cis- and trans- mixture)>98.0%(GC)25g

TERT-BUTYL 2-BROMO-5-FLUOROBENZOATE, 95.0%, 250mg

2,4-Dibromo-1-methoxynaphthalene, 95+%, 10g

(1E,4E)-1,5-Bis[3,5-bis(methoxymethoxy)phenyl]-1,4-pentadiene-3-one>97.0%(HPLC)20mg

2,2,4-Trimethyl-1,2-dihydroquinoline, 95.0%, 100g

2-(1H-Tetrazol-5-yl)benzonitrile, 97%, 1g

4,4'-(Ethane-1,2-diyl)bis(piperazine-2,6-dione), 98%, 1g

n-(1,2,3,4-Tetrahydroquinolin-3-yl)acetamide, 95%, 500mg

2,6-Dichloro-5-(trifluoromethyl)nicotinonitrile, 95.0%, 100mg

Ethyl 6-[3-(N,N-Dimethylamino)phenyl]-6-oxohexanoate, 97.0%, 1g